Percheron Therapeutics Ltd Capital Reinvestment Ratio
Percheron Therapeutics Ltd capital reinvestment ratio. Percheron Therapeutics Ltd (PER) has a Capital Reinvestment Ratio of 0.01x as of September 2015, meaning it reinvests 0% of its operating cash flow (AU$317.22K) in capital expenditures (AU$1.90K). Check PER cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Percheron Therapeutics Ltd (2015–2015)
Capital reinvestment ratio of Percheron Therapeutics Ltd from 2015 to 2015. This chart tracks Percheron Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Percheron Therapeutics Ltd (PER) net asset momentum to track the company's year-over-year net asset growth rate.
Percheron Therapeutics Ltd Capital Reinvestment Ratio by Year (2015–2015)
Percheron Therapeutics Ltd capital reinvestment ratio by year from 2015 to 2015. For the full cash flow conversion analysis, see Percheron Therapeutics Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.00x | AU$1.27 Million | AU$3.86K | — |